NCT05277051
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05277051
Title First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | GBR | FRA | ESP | CAN | AUS

Facility Status City State Zip Country Details
GSK Investigational Site San Francisco California 94158 United States Details
GSK Investigational Site Charlotte North Carolina 28204 United States Details
GSK Investigational Site Oklahoma City Oklahoma 73104 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19111 United States Details
GSK Investigational Site Dallas Texas 75230 United States Details
GSK Investigational Site San Antonio Texas 78229 United States Details
GSK Investigational Site Salt Lake City Utah 84112 United States Details
GSK Investigational Site Nedlands Western Australia 6009 Australia Details
GSK Investigational Site Ottawa Ontario K1H 8L6 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Chengdu 610041 China Details
GSK Investigational Site Jinan 250117 China Details
GSK Investigational Site Shanghai 200126 China Details
GSK Investigational Site Wuhan 430022 China Details
GSK Investigational Site Dijon 21000 France Details
GSK Investigational Site Lille 59000 France Details
GSK Investigational Site Chiba 277-8577 Japan Details
GSK Investigational Site Tokyo 104-0045 Japan Details
GSK Investigational Site Seoul 03080 South Korea Details
GSK Investigational Site Seoul 03722 South Korea Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Madrid 28040 Spain Details
GSK Investigational Site Madrid 28050 Spain Details
GSK Investigational Site Málaga 29010 Spain Details
GSK Investigational Site Manchester M20 4BX United Kingdom Details
GSK Investigational Site Sutton SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field